Literature DB >> 20122341

Clinical significance of the expression of galectin-3 and Pim-1 in laryngeal squamous cell carcinoma.

Ji Yun Choi, Sung Il Cho, Nam Yong Do, Cha Young Kang, Sung Chul Lim.   

Abstract

BACKGROUND: Because advanced-stage squamous cell carcinoma of the larynx undergoes a generally poor hospital course, the prognostic significance of squamous cell carcinoma in the larynx was evaluated to identify those features associated with aggressive biologic behaviour according to the immunologic and histopathologic characteristics. Molecular prognostic and predictive factors have been extensively studied in different cancers over the past decades, and some of these factors were found to be useful in diagnosis, follow-up, or even treatment of some malignant tumours. AIMS: To concretize the pathogenesis of malignant tumours in the larynx and to examine the possible prognostic factors related to malignancy.
METHODS: To assess the significance of galectin-3 and Pim-1 protein in laryngeal tumours and their correlation with prognostic factors, samples from 77 patients with squamous cell carcinoma of the larynx were studied immunohistochemically. We examined the correlations of galectin-3 and Pim-1 protein expression according to tumour stage, nodal status, clinical stage, and histologic differentiation to investigate the clinical significance.
RESULTS: Squamous cell carcinoma showed increased galectin-3 and Pim-1 expression in the more advanced clinical stage, tumour stage, and nodal status.
CONCLUSIONS: The pathogenetic role of galectin-3 and Pim-1 expression in laryngeal squamous cell carcinoma indicates that galectin-3 and Pim-1 might be used as a possible prognostic factor.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20122341

Source DB:  PubMed          Journal:  J Otolaryngol Head Neck Surg        ISSN: 1916-0208


  5 in total

1.  The expressions and clinical significances of tissue and serum galectin-3 in pancreatic carcinoma.

Authors:  Ling Xie; Wen-Kai Ni; Xu-Dong Chen; Ming-Bing Xiao; Bu-You Chen; Song He; Cui-Hua Lu; Xiao-Yan Li; Feng Jiang; Run-Zhou Ni
Journal:  J Cancer Res Clin Oncol       Date:  2012-02-25       Impact factor: 4.553

Review 2.  Why target PIM1 for cancer diagnosis and treatment?

Authors:  Nancy S Magnuson; Zeping Wang; Gang Ding; Raymond Reeves
Journal:  Future Oncol       Date:  2010-09       Impact factor: 3.404

3.  Expression of galectin-3 in pancreatic ductal adenocarcinoma.

Authors:  Matthias M Gaida; Sylvia T Bach; Frank Günther; Billur Baseras; Darjus F Tschaharganeh; Thilo Welsch; Klaus Felix; Frank Bergmann; Gertrud M Hänsch; Moritz N Wente
Journal:  Pathol Oncol Res       Date:  2011-09-12       Impact factor: 3.201

4.  PIM1 polymorphism and PIM1 expression as predisposing factors of esophageal squamous cell carcinoma in the Asian population.

Authors:  Yuan-Bo Wu; Di Lu; Zhi-Feng He; Chan-Guan Jin
Journal:  Onco Targets Ther       Date:  2016-05-17       Impact factor: 4.147

5.  Pim-1 acts as an oncogene in human salivary gland adenoid cystic carcinoma.

Authors:  Xin Zhu; Jia-jie Xu; Si-si Hu; Jian-guo Feng; Lie-hao Jiang; Xiu-xiu Hou; Jun Cao; Jing Han; Zhi-qiang Ling; Ming-hua Ge
Journal:  J Exp Clin Cancer Res       Date:  2014-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.